日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy

MAGIC:法瑞西单抗治疗非增殖性糖尿病视网膜病变的II期临床试验的研究设计和原理

Zhou, Avery W; Sahraravand, Ryan A; Baumann, Liisa M; Teagle, Gail Megan; Brown, Jeremiah; Pieramici, Dante; Holy, Sarah E; Borne, Michael J; Wong, Robert W; Cunningham, Matthew A; Pearce, William A; Rahman, Effie Z; Chang, Margaret; Bhavsar, Abdhish R; Brown, David M; Alfaro, Daniel Virgil; Fan, Kenneth C; Cehofski, Lasse Jørgensen; Ip, Michael; Sadda, Srinivas R; Lesmes, Luis A; Ehlers, Justis P; Chaudhary, Varun; Al-Khersan, Hasenin; Wykoff, Charles C

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial

在无黄斑水肿的非增殖性糖尿病视网膜病变中,使用雷珠单抗进行静脉输注治疗与监测的比较:Pavilion随机临床试验

Pieramici, Dante J; Awh, Carl C; Chang, Margaret; Emanuelli, Andres; Holekamp, Nancy M; Hu, Allen Y; Suñer, Ivan J; Wykoff, Charles C; Brittain, Christopher; Howard, Dena; Quezada-Ruiz, Carlos; Santhanakrishnan, Anjana; Latkany, Paul

Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease

转化生物标志物发现:从实验室到临床——干眼症

Jones, Jeremy; Frenia, Kyla; Gelman, Julia; Beatty, Maria; Zhou, Melody; Ma, Levin; Pieramici, Sean; Eger, Noah; Dhaliwal, Deepinder; Labriola, Leanne T; Xiao, Kunhong

Structural Updates to the Implant and Refill Needle of the Port Delivery Platform

植入和补充针的结构更新(端口输送平台)

Pieramici, Dante J; Campochiaro, Peter A; Chang, Margaret; Pearce, Ian; Regillo, Carl D; Gune, Shamika; Holekamp, Nancy; Quezada-Ruiz, Carlos; Ranade, Shrirang V; Singh, Natasha; Wise, Geoffrey; Horvath, Joshua

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

在美国开展的一项前瞻性、为期两年、多中心1期临床试验(OPTIC),旨在评估ixoberogene soroparvovec治疗新生血管性年龄相关性黄斑变性的安全性和有效性。

Khanani, Arshad M; Boyer, David S; Wykoff, Charles C; Regillo, Carl D; Busbee, Brandon G; Pieramici, Dante; Danzig, Carl J; Joondeph, Brian C; Major, James C Jr; Turpcu, Adam; Kiss, Szilárd

Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices

视网膜诊疗中抗VEGF药物的预先授权

Dang, Sabin; Parke, D Wilkin; Sodhi, Guneet S; Eichenbaum, David; Nielsen, Jared; Danzig, Carl; Lalwani, Geeta; Moinfar, Nader; London, Nikolas; Kimura, Alan; Jumper, J Michael; Lord, Ken; Sheth, Veeral; Pieramici, Dante; Orlin, Anton; Madson, Allison; Horton, Monica; Blim, Jill; Cao, Jessica A; Thompson, John; Khanna, Saira; Wykoff, Charles C; Shah, Ankoor R

Do We Become More Lonely With Age? A Coordinated Data Analysis of Nine Longitudinal Studies

我们年纪越大越孤独吗?一项基于九项纵向研究的协调数据分析

Graham, Eileen K; Beck, Emorie D; Jackson, Kathryn; Yoneda, Tomiko; McGhee, Chloe; Pieramici, Lily; Atherton, Olivia E; Luo, Jing; Willroth, Emily C; Steptoe, Andrew; Mroczek, Daniel K; Ong, Anthony D

Longitudinal Associations Between Multimorbidities and Patient-Reported Quality of Life

多种疾病与患者自述生活质量之间的纵向关联

Graham, Eileen K; Atherton, Olivia E; Mroczek, Daniel K; McGhee, Chloe; Pieramici, Lily; Lewis-Thames, Marquita; Curtis, Laura; Cella, David; Opsasnick, Lauren; Lovett, Rebecca; O'Conor, Rachel; Wolf, Michael S

A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy

一项针对地图状萎缩患者的 GEM103(重组人补体因子 H)的 I 期单次递增剂量研究

Khanani, Arshad M; Maturi, Raj K; Bagheri, Nika; Bakall, Benjamin; Boyer, David S; Couvillion, Stephen S; Dhoot, Dilsher S; Holekamp, Nancy M; Jamal, Karim N; Marcus, Dennis M; Pieramici, Dante; Aziz, Aamir A; Patki, Kiran C; Bridges, William Z Jr; Barone, Samuel B

Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration

在 Ladder II 期试验中,采用 Port 给药系统联合雷珠单抗治疗新生血管性年龄相关性黄斑变性的药代动力学研究

Wykoff, Charles C; Campochiaro, Peter A; Pieramici, Dante J; Khanani, Arshad M; Gune, Shamika; Maia, Mauricio; Kågedal, Matts; Ding, Han Ting; Maass, Katie F